Pillstats
Rx only · Injection, Solution · Intravenous

Paclitaxel

Paclitaxel

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)56946
US makers10 labelers
Packages24
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.3K13K19K25K2025 Q12025 Q22025 Q32025 Q42026 Q1
14K
Rx · 2026 Q1
448K
Units dispensed
-34%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown4SUPPLYING
Novadoz Pharmaceuticals LLCunknown3SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
Natco Pharma Limitedunknown3SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown3SUPPLYING
Sagent Pharmaceuticalsunknown3SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
BluePoint Laboratoriesunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 8, 2013
    RECALLRecall (Class III): PACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); Rx Only; Ma…

    Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections. — Recalling firm: Fresenius Kabi USA, LLC — US: Nationwide and Puerto Rico

  • Jun 27, 2012
    RECALLRecall (Class II): Paclitaxel Injection, 6 mg/mL, 50 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for Hospir…

    The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. — Recalling firm: Hospira Inc. — Nationwide, including Puerto Rico and Guam. Product was also distributed internationally to Australia, Belgium, Cana…